22-(TERT-BUTOXYCARBONYL)-41,41-DIMETHYL-10,19,24,39-TETRAOXO-3,6,12,15,40-PENTAOXA-9,18,23-TRIAZADOTETRACONTANOIC ACID, (S)-
UNII GBB9WQ2LN7
Substance Identification & Data
This profile provides standardized clinical and technical data for 22-(tert-butoxycarbonyl)-41,41-dimethyl-10,19,24,39-tetraoxo-3,6,12,15,40-pentaoxa-9,18,23-triazadotetracontanoic Acid, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GBB9WQ2LN7.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2253870-61-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C41H75N3O13 PNQSMLXIJKGZGV-XIFFEERXSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 22-(tert-butoxycarbonyl)-41,41-dimethyl-10,19,24,39-tetraoxo-3,6,12,15,40-pentaoxa-9,18,23-triazadotetracontanoic Acid, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.